Johns Hopkins University decreased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 0.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 453,433 shares of the exchange traded fund’s stock after selling 318 shares during the quarter. SPDR S&P Biotech ETF comprises 1.7% of Johns Hopkins University’s holdings, making the stock its 10th biggest position. Johns Hopkins University owned approximately 0.59% of SPDR S&P Biotech ETF worth $42,038,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also made changes to their positions in the company. ICA Group Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $27,000. Scarborough Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $32,000. BOCHK Asset Management Ltd purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth about $36,000. ORG Partners LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the second quarter worth about $40,000. Finally, Vima LLC purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $45,000.
SPDR S&P Biotech ETF Trading Up 2.2 %
Shares of NYSEARCA:XBI opened at $101.21 on Monday. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The company’s 50 day moving average is $98.48 and its 200 day moving average is $93.85. The company has a market cap of $7.71 billion, a PE ratio of 11.47 and a beta of 1.11.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- What is a Death Cross in Stocks?
- Analysts See 51% Upside in Coinbase, Is It Time to Buy the Hype?
- Why Invest in 5G? How to Invest in 5G Stocks
- 3 Defensive Stock Alternatives to Bonds If Interest Rates Drop
- What is MarketRank™? How to Use it
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.